YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Report: AstraZeneca explores tie-up with Bristol Myers Squibb

Posted online

AstraZeneca is in talks to combine with Bristol Myers Squibb, people familiar with the matter told the Financial Times.

The proposed deal is reportedly valued at nearly $400 billion.

The companies have held discussions about a tie-up in recent months, the sources said.

Read more from the Financial Times.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences